Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC4 | O15439 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.38 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254002 | 1.00 | ABCC4 (0.63) | ABCC4MAPTALDH1A1LMNAMAOA | |
| SCHEMBL29915565 | 0.96 | ABCC4 (0.59) | ABCC4MAPTALDH1A1LMNAMAOA | |
| SCHEMBL16925547 | 0.94 | ABCC4 (0.59) | ABCC4MAPTALDH1A1LMNAMAOA | |
| SCHEMBL93540 | 0.85 | — | — | |
| SCHEMBL18045567 | 0.84 | MAOA (0.50) | ALDH1A1LMNAMAOAMAOBTSHR | |
| SCHEMBL18045569 | 0.84 | MAOA (0.50) | ALDH1A1LMNAMAOAMAOBTSHR | |
| SCHEMBL30972193 | 0.84 | ABCC4 (0.70) | ABCC4MAPTALDH1A1LMNATSHR | |
| SCHEMBL18045572 | 0.82 | MAOA (0.46) | ALDH1A1LMNAMAOAMAOBTSHR | |
| SCHEMBL1033281 | 0.80 | EPHX2 (0.42) | MAPTLMNAEPHX2 | |
| SCHEMBL4808838 | 0.80 | ABCC4 (0.44) | ABCC4MAPTALDH1A1LMNAMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2351848-B1 | METHOD FOR PRODUCING L-AMINO ACID | KANEKA CORP (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-9464306-B2 | Method for producing L-amino acid | KANEKA CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| CN-102203274-A | Process for producing L-amino acid | KANEKA CORP | 2011-09-28 | — | — | CN | disclosed |
| US-20110229940-A1 | METHOD FOR PRODUCING L-AMINO ACID | KANEKA CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| EP-2351848-A1 | METHOD FOR PRODUCING L-AMINO ACID | Kaneka Corporation (JP) | 2011-08-03 | — | — | EP | disclosed |
| WO-2007148135-A1 | MACROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) | 2007-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110229940-A1 | METHOD FOR PRODUCING L-AMINO ACID | ADSL, ASNS, AASDHPPT | ABCC4 4680/4885MAPT 2698/4885ALDH1A1 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.